本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

萬基遺傳

10.01
+0.10001.01%
盤後10.010.00000.00%17:39 EDT
成交量:190.50萬
成交額:1,909.86萬
市值:9.14億
市盈率:-7.10
高:10.30
開:9.79
低:9.68
收:9.91
資料載入中...

公司資料

公司名字:
萬基遺傳
交易所:
NASDAQ
成立時間:
1991
員工人數:
2700
公司地址:
322 North 2200 West,Salt Lake City,Utah,United States
郵編:
84116
電話:
傳真:
801 584 3640
簡介:
Myriad Genetics, Inc.是特拉華州的一家公司。該公司是一家領先的基因檢測和精準醫療公司,致力於促進所有人的健康和福祉。該公司提供的洞察力幫助人們控制自己的健康,並使醫療保健提供者能夠更好地發現、治療和預防疾病。該公司開發並提供測試,幫助評估疾病或疾病進展的風險,並指導跨醫學專業的治療決策,在這些專業中,基因洞察力可以顯著改善患者護理並降低醫療成本。

董事

名稱
職位
Paul J. Diaz
President, Chief Executive Officer, Director
S. Louise Phanstiel
Chair of the Board, Director
Colleen F. Reitan
Director
Daniel K. Spiegelman
Director
Daniel Skovronsky
Director
Dennis H. Langer
Director
Heiner Dreismann
Director
John T. Henderson
Director
Lawrence C. Best
Director
Lee N. Newcomer
Director
Rashmi Kumar
Director
Walter Gilbert
Director

股東

名稱
職位
Paul J. Diaz
President, Chief Executive Officer, Director
R. Bryan Riggsbee
Chief Financial Officer and Treasurer
Benjamin G. Jackson
Executive Vice President, General Counsel and Secretary
Jayne B. Hart
Executive Vice President of Human Resources
Jerry S. Lanchbury
Chief Scientific Officer
Mark Verratti
President, Myriad Neuroscience
Nicole Lambert
President of Myriad Womens Health, Oncology, and International
Paul C. Parkinson
Executive Vice President for Reimbursement Strategy